Canada markets closed

Waverley Pharma Inc. (WAVE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.03500.0000 (0.00%)
At close: 01:09PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 1.89M
Enterprise Value 3.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.48
Price/Book (mrq)9.83
Enterprise Value/Revenue 5.52
Enterprise Value/EBITDA -4.23

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 316.67%
S&P500 52-Week Change 320.07%
52 Week High 30.0400
52 Week Low 30.0150
50-Day Moving Average 30.0294
200-Day Moving Average 30.0293

Share Statistics

Avg Vol (3 month) 34.23k
Avg Vol (10 day) 37k
Shares Outstanding 554M
Implied Shares Outstanding 663M
Float 813.61M
% Held by Insiders 174.80%
% Held by Institutions 10.00%
Shares Short (Dec 15, 2023) 48k
Short Ratio (Dec 15, 2023) 42.9
Short % of Float (Dec 15, 2023) 4N/A
Short % of Shares Outstanding (Dec 15, 2023) 40.01%
Shares Short (prior month Apr 28, 2023) 4398

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -202.32%
Operating Margin (ttm)-292.80%

Management Effectiveness

Return on Assets (ttm)-35.17%
Return on Equity (ttm)-136.53%

Income Statement

Revenue (ttm)542.61k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-71.90%
Gross Profit (ttm)N/A
EBITDA -1.06M
Net Income Avi to Common (ttm)-1.1M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)31.56k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)591.89%
Current Ratio (mrq)0.17
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-727.64k
Levered Free Cash Flow (ttm)-509.74k